Delivery Order SPE2DB22D2007-SPE2DB24FH8GF
- Not listed
- The federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Dupixent 200 mg/1.14 ml syringes. The $11,027.46 firm fixed price contract runs from March 8, 2024 to March 11, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml syringes. The ceiling value of the delivery order is $11,416.48, with a period of performance through March 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $14,402.52, is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml syringe, 2 ml. The contract is a Firm Fixed Price Delivery Order, with a period of performance ending on May 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml syringes. The contract has a ceiling value of $14,228.73 and an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). The contract is a Delivery Order and utilizes a Firm...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Dupixent 300 mg/2 ml syringes. The contract has a ceiling value of $38,757.47 and an ultimate completion date of March 11, 2024. This award is a delivery order placed under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. The IDC has a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Dupixent 300 mg/2 ml syringes. The $6,422.04 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of February 3, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,957.08, is for the delivery of the medication Dupixent 200 mg/1.14 ml syringe. This is a firm-fixed-price delivery order contract with an ultimate completion date of December 3, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $31,160.74 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes, a specialty pharmaceutical product. The contract has a completion date of May 11, 2023. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $2,441.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Dupixent 200 mg/1.14 ml syringes, a specialty pharmaceutical product, with a completion date of December 8, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml syringes. The firm-fixed-price delivery order has a ceiling value of $8,204.99 and runs through April 1, 2025. The contract is not set aside for any specific type of business. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH8GFDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml syringes. The contract has a ceiling value of $41,136.98 and a completion date of January 4, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, running through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.1k | 1/3/24 |